A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy in Switzerland and Austria Receiving Oral Venetoclax Tablets
Clinical trial NCT05215639 · COMPLETED
Trial details
- NCT number
- NCT05215639
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-12-27
- Primary completion
- 2025-11-24
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.